Plus Therapeutics Ownership | Who Owns Plus Therapeutics?


OverviewForecastRevenueFinancialsChartTranscripts

Plus Therapeutics Ownership Summary


Plus Therapeutics is owned by 6.60% institutional investors, 17.87% insiders, and 75.53% retail investors. Fidelity Extended Market Index is the top mutual fund, with 0.21% of its assets in Plus Therapeutics shares.

PSTV Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockPlus Therapeutics6.60%17.87%75.53%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 20251660.00%389,160-42.62%64.99%10150.00%2-
Dec 31, 202410-678,1730.98%1115.74%4---100.00%
Sep 30, 202410-16.67%671,584-1.47%87.78%4-42.86%2-
Jun 30, 20241220.00%681,594575.03%10192.07%7133.33%--100.00%
Mar 31, 202410-16.67%100,972-27.84%211.77%3-57.14%2100.00%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index35.04K0.21%828.00
Vanguard Institutional Extnd Mkt Idx Tr32.54K0.19%-
Fidelity Nasdaq Composite Index8.90K0.05%-
Fidelity Series Total Market Index8.28K0.05%-
Fidelity Total Market Index5.32K0.03%-
Northern Trust Extended Eq Market Idx2.33K0.01%-
NT Ext Equity Mkt Idx Fd - L2.33K0.01%-
Spartan Extended Market Index Pool E741.000.01%218.00
SSgA U.S. Extended Market Index Class I663.000.01%-
NT Ext Eq Mkt Indx Fd DC Lend T3556.000.01%556.00

Recent Insider Transactions


DateNameRoleActivityValue
Sep 13, 2024Hawkins Richard J-Buy$6.00K
Sep 12, 2024Hawkins Richard J-Buy$8.51K
Sep 11, 2024Petersen Greg-Buy$16.88K
Sep 11, 2024Clowes Howard-Buy$6.68K
Sep 10, 2024HEDRICK MARC H Chief Executive OfficerBuy$9.84K

Insider Transactions Trends


DateBuySell
2025 Q1--
2024 Q36-
2024 Q26-
2024 Q1--
2023 Q481

PSTV Ownership FAQ


Who Owns Plus Therapeutics?

Plus Therapeutics shareholders are primarily institutional investors at 6.60%, followed by 17.87% insiders and 75.53% retail investors. The average institutional ownership in Plus Therapeutics's industry, Biotech Stocks , is 63.96%, which Plus Therapeutics falls below.

Does Blackrock own Plus Therapeutics?

BlackRock is not among the top 10 institutional shareholders of Plus Therapeutics.

Who is the top mutual fund holder of Plus Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Plus Therapeutics shares, with 0.21% of its total shares outstanding invested in 35.04K Plus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools